Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Studies from J.H. Rubenstein and co-researchers update current data on adenocarcinoma
December 30th, 2008
"The efficacy of screening and surveillance EGD for esophageal adenocarcinoma (EAC) is controversial. To examine the effect of an EGD before the diagnosis of EAC on survival after the diagnosis of cancer among patients with gastroesophageal reflux (GER)," investigators in the United States report. "A retrospective, controlled cohort study. The national administrative databases of the Veterans Affairs were accessed, and patients diagnosed with EAC, from 1995 through 2003, who had a prior diagnosis consistent with GER were identified. Electronic medical records were then abstracted. Cases were subjects who had an EGD performed between 1 and 5 years before the diagnosis of...
Source: Cancer Weekly (2008-12-30)
|
